论文部分内容阅读
目的:探究三联疗法联合康复新液治疗幽门螺杆菌相关性胃溃疡的效果。方法:把我院收治的162例幽门螺杆菌相关性胃溃疡患者作为此次观察对象,随机分为观察组(81例)和对照组(81例)。给对照组患者用三联疗法治疗,给观察组患者用三联疗法联合康复新液治疗,观察并记录两组患者的治疗效果、幽门螺杆菌清除情况和复发情况。结果:总有效率方面,对照组和观察组分别为72.84%、86.42%,差异具有统计学意义(P<0.05);在幽门螺杆菌清除率方面,对照组低于观察组(P<0.05);在复发率方面,对照组高于观察组(P<0.05)。结论:在幽门螺杆菌相关性胃溃疡的治疗上,三联疗法联合康复新液方案效果显著,幽门螺杆菌清除率高,复发率低。
Objective: To investigate the effect of triple therapy combined with rehabilitation new liquid on Helicobacter pylori-associated gastric ulcer. Methods: 162 cases of H. pylori-associated gastric ulcer admitted to our hospital were randomly divided into observation group (81 cases) and control group (81 cases). The patients in the control group were treated with triple therapy and the patients in the observation group were treated with triple therapy combined with rehabilitation new liquid. The therapeutic effect, the clearance of Helicobacter pylori and the recurrence of H. pylori were observed and recorded in both groups. Results: The total effective rate was 72.84% in the control group and 86.42% in the observation group, the difference was statistically significant (P <0.05); in Helicobacter pylori clearance rate, the control group was lower than the observation group (P <0.05) In the recurrence rate, the control group was higher than the observation group (P <0.05). Conclusion: The combination of triple therapy and rehabilitation complex solution is effective in the treatment of Helicobacter pylori-associated gastric ulcer. The H. pylori has high clearance rate and low recurrence rate.